BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Várkonyi I, Chappey C, Giraudon M, Burleigh L. A part-randomized study of intravenous oseltamivir in adolescents and adults. Eur J Clin Microbiol Infect Dis 2015;34:1181-8. [PMID: 25678009 DOI: 10.1007/s10096-015-2338-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Mc Mahon A, Martin-Loeches I. The pharmacological management of severe influenza infection - 'existing and emerging therapies'. Expert Rev Clin Pharmacol 2017;10:81-95. [PMID: 27797595 DOI: 10.1080/17512433.2017.1255550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
2 Nakamura Y, Sasaki R, Cao X, Wada T, Hamaguchi S, Izumi-Nakaseko H, Ando K, Tanaka H, Takahara A, Sugiyama A. Intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: Evidences from proarrhythmia model and action-potential assay. J Pharmacol Sci 2016;131:72-5. [PMID: 27174864 DOI: 10.1016/j.jphs.2016.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]